Back to Journals » Cancer Management and Research » Volume 13

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

Total article views   Abstract views HTML views PDF downloads Totals
553 Dovepress* 266 287+ 60 553
Totals 266 287 60 553
*Since 15 February 2021
+Since July 2016

View citations on Google Scholar